Arthur Krieg to Injections, Intravenous
This is a "connection" page, showing publications Arthur Krieg has written about Injections, Intravenous.
Connection Strength
0.108
-
Krieg AM, Efler SM, Wittpoth M, Al Adhami MJ, Davis HL. Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist. J Immunother. 2004 Nov-Dec; 27(6):460-71.
Score: 0.057
-
Schwartz DA, Wohlford-Lenane CL, Quinn TJ, Krieg AM. Bacterial DNA or oligonucleotides containing unmethylated CpG motifs can minimize lipopolysaccharide-induced inflammation in the lower respiratory tract through an IL-12-dependent pathway. J Immunol. 1999 Jul 01; 163(1):224-31.
Score: 0.039
-
Myers LP, Krieg AM, Pruett SB. Bacterial DNA does not increase serum corticosterone concentration or prevent increases induced by other stimuli. Int Immunopharmacol. 2001 Aug; 1(8):1605-14.
Score: 0.011